Administer intravenously (IV) to achieve optimal absorption and quicker results
Is it still good
These applications remain speculative pending human research, but the biological plausibility is strong
The lack of comprehensive endotoxin testing and selective batch verification raises questions about paying double budget vendor costs for marginally better quality assurance
When administered to patients with Type 2 Diabetes at doses of 200240 g/kg/day, it significantly reduced blood glucose levels (Moses, Young, Morrow et al., 1996, Zenobi, Jaeggigroisman, Riesen et al., 1992)
Depending on the study, 12-82% of patients newly diagnosed with celiac disease have iron deficiency